Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
2,15,17,29-tetrahydroxy-27-(4-iodophenylcarbamoylmethoxy)-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1,3,5(28),9,19,21,25(29),26-octaen-13-yl acetate; (rifamycin B)
ID: ALA307649
PubChem CID: 6507126
Max Phase: Preclinical
Molecular Formula: C45H53IN2O13
Molecular Weight: 956.82
Molecule Type: Small molecule
Associated Items: